Search for Clinical Trials
Combination of Induction Durvalumab and Tremelimumab alone versus Durvalumab and Tremelimumab with chemotherapy for Potentially Resectable Pleural…
Objective:
Study ML41591 is an umbrella trial that will evaluate the efficacy and safety of various therapies in patients with Stage IB, IIA,…
The purpose of this research study is to investigate a potential treatment for quitting smoking and preventing post-quit weight gain. This study will…
A Randomized, Double-blind, Placebo-controlled, Phase 3 Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects with Idiopathic…
Background: Studies have reported differences in the care provided according to the sex and race of the patient. A PE in the lungs can lead to…
Objective: To determine the effects of combined therapeutic plasma exchange (TPE), rituximab, and intravenous immunoglobulin (IVIG) in comparison to…
Study Product: CSL312 (Garadacimab, factor XIIa antagonist monoclonal antibody) for treatment of idiopathic pulmonary fibrosis (IPF).
Inclusion…
Study To Evaluate Perioperative Circulating Tumor DNA As A Prognostic Biomarker In Patients Undergoing Neoadjuvant Therapy For Resectable Non-Small…
Objective:
The primary objective is to determine lung cancer–specific survival at 5 years among patients undergoing active surveillance for GGOs.…
A phase 3, prospective, multicenter, double-blind, double-dummy, randomized, active controlled, parallel-group, group-sequential, adaptive, event-…
